Form 4/A for ARVN ARVINAS, INC.
Accepted 2022-08-16 00:00:00 ET · period of report 2022-08-12 · accession 0001655759-22-000034 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DA | 2022-08-16 | 2022-08-12 | ARVN | Peck Ronald | Chief Medical Off | M - OptEx | — | +4,010 | 9,412 | +74% | — |
| DA | 2022-08-16 | 2022-08-12 | ARVN | Peck Ronald | Chief Medical Off | S - Sale+OE | $54.84 | -1,258 | 8,154 | -13% | -$69.0K |
| DA | 2022-08-16 | 2022-08-12 | ARVN | Peck Ronald | Chief Medical Off | M - OptEx | $0.00 | -4,010 | 4,010 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-12 | M | A | 4,010 | — | 9,412 | D | — | — | (F1) Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. |
| 2 | Common | Common Stock | 2022-08-12 | S | D | 1,258 | $54.84 | 8,154 | D | — | — | (F2) This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units. (F3) This amendment is being filed to correct the sales price reported on the reporting person's Form 4 filed on August 16, 2022. |
| 3 | Derivative | Restricted Stock Units | 2022-08-12 | M | D | 4,010 | $0.00 | 4,010 | D | — · — to — | 4,010 Common Stock | (F1) Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. (F4) On July 29, 2019, the reporting person was granted 16,041 Restricted Stock Units, vesting in four equal annual installments beginning July 29, 2020. |